AI brings millions in savings to cancer clinical trials
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- AI is unlocking millions of dollars' worth of new efficiencies in clinical trials on cancer treatments, per research shared first with Axios.
- AI-powered tools could shave months off time-consuming trial processes, extending AI's established role in speeding up early-stage drug development.
Why it matters: AI tools unlocking millions in cancer clinical trial savings are driving down the cost and time of the most expensive phase of drug development, per Axios-shared research. For pharma companies and patients, this compresses the timeline of getting new cancer therapies to market and reduces the cost burden of late-stage trials.
Ask SkimNews
